The Cancer Discovery Hub (CDH) is a one-stop pan-omics diagnostic and research core laboratory located at the National Cancer Centre Singapore. It specialises in state-of-the-art research-grade technologies and provides expert support and mentorship to investigators on all cancer-related projects. It strives to be at the forefront of cutting-edge cancer research, enabling preclinical therapeutic development and supporting clinical trials for biomarker discovery. The research team supports several key cancer research programs in Singapore, including TETRAD (Targeted Therapy for Blood Cancer), SYMPHONY (Singapore lYMPHoma translatiONal study), STARLIGHT (Steering Translational Rare Cancer Research into the Light), and the KKH CBCC (KK Women's and Children's Hospital Children's Blood and Cancer Centre). The lab also supports the Singapore Translational Cancer Consortium (STCC), coordinating large-scale collaborative studies at the national level.
All
Products
Resources
News
FAQ
Search